JW Lifescience Corporation (KRX:234080)

JW Lifescience Revenue

JW Lifescience had revenue of 63.52B KRW in the quarter ending March 31, 2026, a decrease of -7.44%. This brings the company's revenue in the last twelve months to 252.72B, up 7.19% year-over-year. In the year 2025, JW Lifescience had annual revenue of 257.83B with 15.89% growth.

• Revenue (ttm): 252.72B
• Revenue Growth: +7.19%
• P/S Ratio: 0.69
• Revenue / Employee: 850.91M
• Employees: 297
• Market Cap: 174.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	257.83B	35.35B	15.89%
Dec 31, 2024	222.48B	15.62B	7.55%
Dec 31, 2023	206.86B	17.93B	9.49%
Dec 31, 2022	188.93B	19.11B	11.26%
Dec 31, 2021	169.82B	-13.70B	-7.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 31, 2026

Data Sources Report a data error